Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 4 | $158,451 |
Sells | 22 | $6,193,726 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
10 Jun 2024 16:29 | APLT | Applied Therapeutics Inc | SHENDELMAN SHOSHANA | President and CEO, 10% | 06 Jun 2024 | Sale | 61,795 | 4.32 | 266,954 | D |
10 Jun 2024 16:28 | APLT | Applied Therapeutics Inc | PERFETTI RICCARDO | Chief Medical Officer | 06 Jun 2024 | Sale | 22,003 | 4.32 | 95,053 | D |
10 Jun 2024 16:25 | APLT | Applied Therapeutics Inc | FUNTLEYDER LESLIE D. | Chief Financial Officer | 06 Jun 2024 | Sale | 16,980 | 4.32 | 73,354 | D |
06 Jun 2024 18:45 | APLT | Applied Therapeutics Inc | ALEXANDRIA REAL ESTATE EQUITIES, INC. | 10% | 05 Jun 2024 | Sale | 150,000 | 4.24 | 636,000 | I |
06 Jun 2024 18:45 | APLT | Applied Therapeutics Inc | ALEXANDRIA REAL ESTATE EQUITIES, INC. | 10% | 04 Jun 2024 | Sale | 150,000 | 4.21 | 631,500 | I |
18 Mar 2024 18:12 | APLT | Applied Therapeutics Inc | SHENDELMAN SHOSHANA | President and CEO, 10% | 14 Mar 2024 | Sale | 318,573 | 5.39 | 1,717,108 | D |
18 Mar 2024 18:02 | APLT | Applied Therapeutics Inc | PERFETTI RICCARDO | Chief Medical Officer | 14 Mar 2024 | Sale | 110,804 | 5.39 | 597,234 | D |
18 Mar 2024 18:00 | APLT | Applied Therapeutics Inc | HANSARD ADAM | Chief Commercial Officer | 14 Mar 2024 | Sale | 48,871 | 5.39 | 263,415 | D |
18 Mar 2024 17:57 | APLT | Applied Therapeutics Inc | FUNTLEYDER LESLIE D. | Chief Financial Officer | 14 Mar 2024 | Sale | 28,727 | 5.39 | 154,839 | D |
05 Dec 2023 19:03 | APLT | Applied Therapeutics Inc | KANTER STACY J. | Director | 01 Dec 2023 | Purchase | 30,000 | 2.1789 | 65,367 | D |
01 Dec 2023 19:42 | APLT | Applied Therapeutics Inc | SHENDELMAN SHOSHANA | President and CEO, 10% | 30 Nov 2023 | Sale | 3,968 | 1.97 | 7,817 | D |
01 Dec 2023 19:42 | APLT | Applied Therapeutics Inc | PERFETTI RICCARDO | Chief Medical Officer | 30 Nov 2023 | Sale | 1,583 | 1.97 | 3,119 | D |
01 Dec 2023 19:42 | APLT | Applied Therapeutics Inc | HANSARD ADAM | Chief Commercial Officer | 30 Nov 2023 | Sale | 965 | 1.97 | 1,901 | D |
06 Nov 2023 16:56 | APLT | Applied Therapeutics Inc | ALEXANDRIA REAL ESTATE EQUITIES, INC. | 10% | 02 Nov 2023 | Sale | 103,808 | 2.32 | 240,835 | I |
06 Nov 2023 16:56 | APLT | Applied Therapeutics Inc | ALEXANDRIA REAL ESTATE EQUITIES, INC. | 10% | 03 Nov 2023 | Sale | 143,450 | 2.31 | 331,370 | I |
02 Nov 2023 16:44 | APLT | Applied Therapeutics Inc | ALEXANDRIA REAL ESTATE EQUITIES, INC. | 10% | 01 Nov 2023 | Sale | 172,742 | 2.36 | 407,671 | I |
02 Nov 2023 16:44 | APLT | Applied Therapeutics Inc | ALEXANDRIA REAL ESTATE EQUITIES, INC. | 10% | 31 Oct 2023 | Sale | 155,000 | 2.41 | 373,550 | I |
29 Sep 2023 20:03 | APLT | Applied Therapeutics Inc | SHENDELMAN SHOSHANA | President and CEO, 10% | 27 Sep 2023 | Sale | 115,632 | 2.7 | 312,206 | D |
29 Sep 2023 20:02 | APLT | Applied Therapeutics Inc | PERFETTI RICCARDO | Chief Medical Officer | 27 Sep 2023 | Sale | 10,932 | 2.7 | 29,516 | D |
29 Sep 2023 20:02 | APLT | Applied Therapeutics Inc | HANSARD ADAM | Chief Commercial Officer | 27 Sep 2023 | Sale | 9,720 | 2.7 | 26,244 | D |
13 Jan 2023 16:34 | APLT | Applied Therapeutics Inc | SHENDELMAN SHOSHANA | President and CEO, 10% | 11 Jan 2023 | Sale | 15,870 | 0.91 | 14,442 | D |
13 Jan 2023 16:32 | APLT | Applied Therapeutics Inc | PERFETTI RICCARDO | Chief Medical Officer | 11 Jan 2023 | Sale | 6,053 | 0.91 | 5,508 | D |
13 Jan 2023 16:30 | APLT | Applied Therapeutics Inc | HANSARD ADAM | Chief Commercial Officer | 11 Jan 2023 | Sale | 4,495 | 0.91 | 4,090 | D |
14 Oct 2022 17:41 | APLT | Applied Therapeutics Inc | SHENDELMAN SHOSHANA | President and CEO, 10% | 14 Oct 2022 | Purchase | 50,000 | 0.645 | 32,250 | D |
13 Oct 2022 18:17 | APLT | Applied Therapeutics Inc | SHENDELMAN SHOSHANA | President and CEO, 10% | 13 Oct 2022 | Purchase | 73,256 | 0.5582 | 40,891 | D |
12 Oct 2022 20:51 | APLT | Applied Therapeutics Inc | SHENDELMAN SHOSHANA | President and CEO, 10% | 12 Oct 2022 | Purchase | 38,153 | 0.5227 | 19,943 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)